Clinical Trials Browser

Phase 2 × entinostat × Genitourinary × Clear all

NCT03978624 2025-10-15

Window of Opportunity Study of Pembrolizumab Alone and in Combinations in Bladder Cancer

Phase 2 Active not recruiting

20 enrolled 11 charts

Urinary Bladder Neoplasms

NCT03552380 2024-09-03

Study of Entinostat With Nivolumab Plus Ipilimumab in Previously Treated Renal Cell Carcinoma

Phase 2 Terminated

12 enrolled 16 charts

Carcinoma, Renal Cell

NCT03501381 2023-09-01

High Dose IL 2 and Entinostat in RCC

Phase 2 Active not recruiting

Carcinoma, Renal Cell